Chargement en cours...

Immunology beats cancer: a blueprint for successful translation

Immunology offers an unprecedented opportunity for the science-driven development of therapeutics. The successes of antibodies to the immunomodulatory receptor CTLA-4 and blockade of the immunoinhibitory receptor PD-1 in cancer immunotherapy, from gene discovery to patient benefit, have created a pa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Immunol
Auteur principal: Pardoll, Drew M
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4659410/
https://ncbi.nlm.nih.gov/pubmed/23160205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ni.2392
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!